Enrichment of regulatory T Cells in acutely rejected human liver allografts

American Journal of Transplantation

Volumn 12, Issue 12, 2012, Pages 3425-3436

  Taubert, R ^a   Pischke, S ^a   Schlue, J ^a   Wedemeyer, H ^a   Noyan, F ^a   Heim, A ^a   Lehner, F ^a   Barg Hock, H ^a   Klempnauer, J ^a   Olek, S ^b   Manns, M P ^a   Hardtke Wolenski, M ^a   Jaeckel, E ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b EPIONTIS GMBH   (Germany)

Author keywords

acute cellular rejection; FOXP3; graft survival; Liver transplantation; regulatory T cell

Indexed keywords

AMINOTRANSFERASE; CALCINEURIN INHIBITOR; CD4 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TACROLIMUS; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT REJECTION; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; EFFECTOR CELL; FEMALE; GRAFT HEPATITIS; HEPATITIS; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REGULATORY T LYMPHOCYTE; SURVIVAL;

ACUTE DISEASE; ADULT; AGED; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GRAFT REJECTION; HUMANS; LEUKOCYTES, MONONUCLEAR; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION, HOMOLOGOUS;

EID: 84870505603     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04264.x     Document Type: Article

References (46)

1. Knechtle SJ, Kwun J,. Unique aspects of rejection and tolerance in liver transplantation. Semin Liver Dis 2009; 29: 91-101.
2. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997; 25: 658-663.
3. Wildin RS, Ramsdell F, Peake J, et al,. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27: 18-20.
4. Bennett CL, Christie J, Ramsdell F, et al,. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001; 27: 20-1.
5. Brunkow ME, Jeffery EW, Hjerrild KA, et al,. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 2001; 27: 68-73.
6. Kingsley CI, Karim M, Bushell AR, et al,. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 2002; 168: 1080-1086.
7. Joffre O, Santolaria T, Calise D, et al,. Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes. Nat Med 2008; 14: 88-92.
8. Gavin MA, Torgerson TR, Houston E, et al,. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A 2006; 103: 6659-6664.
9. Liu W, Xu-Yu Z, Szot GL, et al,. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med 2006; 203: 1701-1711.
10. Seddiki N, Santner-Nanan B, Martinson J, et al,. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 2006; 203: 1693-700.
11. Sakaguchi S, Miyara M, Costantino CM, et al,. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10: 490-500.
12. Miyara M, Yoshioka Y, Kitoh A, et al,. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 2009; 30: 899-911.
13. Baron U, Floess S, Wieczorek G, et al,. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol 2007; 37: 2378-2389.
14. Miyao T, Floess S, Setoguchi R, et al,. Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 2012; 36: 262-275.
15. He Q, Fan H, Li JQ, et al,. Decreased circulating CD4+CD25highFoxp3+ T cells during acute rejection in liver transplant patients. Transplant Proc 2011; 43: 1696-700.
16. Pons JA, Revilla-Nuin B, Baroja-Mazo A, et al,. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal. Transplantation 2008; 86: 1370-1378.
17. Martinez-Llordella M, Puig-Pey I, Orlando G, et al,. Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 2007; 7: 309-319.
18. Li Y, Yoshizawa A, Yonekawa Y, et al,. Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 2004; 4: 2118-2125.
19. Graca L, Cobbold SP, Waldmann H,. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 1641-1646.
20. Demirkiran A, Baan CC, Kok A, et al,. Intrahepatic detection of FOXP3 gene expression after liver transplantation using minimally invasive aspiration biopsy. Transplantation 2007; 83: 819-823.
21. Eguchi S, Hidaka M, Soyama A, et al,. Is liver-targeted FOXp3 staining beneficial after living-donor liver transplantation? Transpl Infect Dis 2012; 14: 156-162.
22. Li Y, Zhao X, Cheng D, et al,. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients. Transplantation 2008; 86: 1837-1843.
23. Stenard F, Nguyen C, Cox K, et al,. Decreases in circulating CD4+CD25hiFOXP3 +cells and increases in intragraft FOXP3+ cells accompany allograft rejection in pediatric liver allograft recipients. Pediatr Transplant 2009; 13: 70-80.
24. Pileri SA, Roncador G, Ceccarelli C, et al,. Antigen retrieval techniques in immunohistochemistry: Comparison of different methods. J Pathol 1997; 183: 116-123.
25. Bestard O, Cruzado JM, Rama I, et al,. Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 2008; 19: 2020-2026.
26. Grimbert P, Mansour H, Desvaux D, et al,. The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection. Transplantation 2007; 83: 341-316.
27. Martin L, Funes de la Vega M, Bocrie O, et al,. Detection of Foxp3+ cells on biopsies of kidney transplants with early acute rejection. Transplant Proc 2007; 39: 2586-2588.
28. Naka EL, Ponciano VC, Rangel EB, et al,. FOXP3-positive regulatory cells inside the allograft and the correlation with rejection. Transplant Proc 2006; 38: 3202-3204.
29. Taflin C, Nochy D, Hill G, et al,. Regulatory T cells in kidney allograft infiltrates correlate with initial inflammation and graft function. Transplantation 2010; 89: 194-199.
30. Veronese F, Rotman S, Smith RN, et al,. Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection. Am J Transplant 2007; 7: 914-922.
31. Zuber J, Brodin-Sartorius A, Lapidus N, et al,. FOXP3-enriched infiltrates associated with better outcome in renal allografts with inflamed fibrosis. Nephrol Dial Transplant 2009; 24: 3847-3854.
32. Kubota N, Sugitani M, Takano S, et al,. Correlation between acute rejection severity and CD8-positive T cells in living related liver transplantation. Transpl Immunol 2006; 16: 60-64.
33. Aquino-Dias EC, Joelsons G, da Silva DM, et al,. Non-invasive diagnosis of acute rejection in kidney transplants with delayed graft function. Kidney Int 2008; 73: 877-884.
34. Madsen CB, Norgaard A, Iversen M, et al,. Elevated mRNA levels of CTLA-4, FoxP3, and Granzyme B in BAL, but not in blood, during acute rejection of lung allografts. Transpl Immunol 2010; 24: 26-32.
35. Xu M, Tan C, Zhou J, et al,. The dynamic changes of T-bet(+)/GATA-3(+) and RORgammat(+)/FOXP3(+) cells in recipient spleens and grafts after rat orthotopic liver transplantation. Transpl Immunol 2010; 22: 165-171.
36. Taflin C, Miyara M, Nochy D, et al,. FoxP3+ regulatory T cells suppress early stages of granuloma formation but have little impact on sarcoidosis lesions. Am J Pathol 2009; 174: 497-508.
37. Duhen T, Duhen R, Lanzavecchia A, et al,. Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. Blood 2012; 119: 4430-4440.
38. Chaudhry A, Rudra D, Treuting P, et al,. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 2009; 326: 986-991.
39. Koch MA, Tucker-Heard G, Perdue NR, et al,. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 2009; 10: 595-602.
40. Zheng Y, Chaudhry A, Kas A, et al,. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 2009; 458: 351-356.
41. Demirkiran A, Kok A, Kwekkeboom J, et al,. Low circulating regulatory T-cell levels after acute rejection in liver transplantation. Liver Transpl 2006; 12: 277-284.
42. Dijke IE, Caliskan K, Korevaar SS, et al,. FOXP3 mRNA expression analysis in the peripheral blood and allograft of heart transplant patients. Transpl Immunol 2008; 18: 250-254.
43. Dijke IE, Velthuis JH, Caliskan K, et al,. Intragraft FOXP3 mRNA expression reflects antidonor immune reactivity in cardiac allograft patients. Transplantation 2007; 83: 1477-1484.
44. Neujahr DC, Cardona AC, Ulukpo O, et al,. Dynamics of human regulatory T cells in lung lavages of lung transplant recipients. Transplantation 2009; 88: 521-527.
45. Bhorade SM, Chen H, Molinero L, Liao C, et al,. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation 2010; 90: 540-546.
46. Yeung MY, Sayegh MH,. Regulatory T cells in transplantation: What we know and what we do not know. Transplant Proc 2009; 41 (6 Suppl): S21-S6.